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ABSTRACT 
 
 
AIM 
To evaluate the efficiency of intraosseous injection of methyl 
prednisolone acetate (Depo-medrol) in reducing pain in untreated and treated 
acute irreversible pulpitis. 
OBJECTIVES:  
1. To evaluate whether intraosseous injection of methyl prednisolone acetate 
is safe to administer in patients. 
2. To evaluate whether intraosseous injection of methyl prednisolone acetate 
is effective in reducing pain in cases of acute irreversible pulpitis. 
3. To evaluate whether patients who are injected intraosseous methyl 
prednisolone acetate required analgesics in 7 day period. 
4. To find out whether it is possible to perform complete pulpectomy under 
local anesthesia on the 7
th
 day in methyl prednisolone acetate group. 
5. To evaluate pain and discomfort   while performing complete pulpectomy 
on the 7
th
 day in patients who are administered methyl prednisolone acetate. 
6. To evaluate whether intraosseous injection of saline is safe to administer in 
patients. 
7. To evaluate whether intraosseous injection of saline is effective in reducing 
pain in cases of acute irreversible pulpitis. 
8. To evaluate whether patients who are injected intraosseous saline require 
analgesics in 7 day period. 
9. To evaluate whether antibiotic prophylaxis was effective in reducing pain in 
acute irreversible pulpitis. 
10. To evaluate whether patients who are administerd prophylactic antibiotics 
require analgesics to control pain due to acute irreversible pulpitis. 
11. To evaluate the effectiveness of 2% lignocaine intaosseus injection in 
reducing pain during pulpectomy on day 0. 
12.  To evaluate whether complete pulpectomy was achievable on day 0 using 
intraosseous administration of 2 % lignocaine. 
13. To evaluate  effectiveness of pulpectomy  done  under 2% lignocaine 
intraosseous injection on day 0,in alleviating pain over a period of 7 days   
14. To evaluate whether patients who are injected intraosseous lignocaine and 
pulpectomy done on day 0 required analgesics over 7 day period. 
15. To evaluate and compare profound anesthesia, pain reduction and ability to 
perform pulpectomy with comfort in patients who were administered 
methyl prednisolone acetate compared to control group (saline), antibiotic 
group and patients where emergency pulpectomy performed with 2% 
lignocaine containing 1:100000 adrenaline. 
METHODOLOGY: 
Eighty patients between age groups 18 to 35 with acute irreversible pulpitis 
pain and requiring emergency treatment participated in the study. Patients are 
divided into 4 groups of 20 each. 
Group I-20 patients were administered intra-osseous methyl prednisolone 
acetate (Depo-Medrol) injection and recalled for pulpectomy on the 7th day. 
Group II-20 patients were administered intra-osseous saline injection and 
recalled on the 7
th
 day for pulpectomy (control group). 
Group III-20 patients were  prescribed with antibiotic prophylaxis (amoxycillin 
500mg thrice daily for 3 days) were recalled on the  7 day for pain evaluation and 
pulpectomy. 
Group IV- In 20 patients intra-osseous injection of 2% lignocaine with 
1:100000 adrenaline was administered. Emergency pulpectomy is attempted. 
Patients are recalled on the 7th day for continuing root canal treatment. 
Group I and II (40 patients) were administered intra-osseous injection of 
either 1ml (40mg/ml) of methyl prednisolone acetate (Depo-medrol) or 1ml of 
0.9% preservative free sterile saline (Sodium chloride). In Group III antibiotic 
prophylaxis prescribed for 3 days and recalled on 7
th
 day for pulpectomy. Pain 
evaluation is done on a pain scale of 0 to 3, (by Gallatin et al). Each patient is 
asked to fill a 7-day questionnaire (survey) every day. They were instructed to 
record pain and percussion pain using the 4-point scale used for the initial pain 
recordings. On the recall appointment on the 7
th
 day for Group I, II and III, pain 
evaluation is done in patients for the duration of seven days. Pulp vitality was 
determined for each patient with electric pulp tester and Endo frost before 
pulpectomy is commenced under nerve block or infiltration. Group IV patients 
were administered on 2% lidocaine with 1:100000 epinephrine intraosseously and 
emergency pulpectomy is performed on day zero. On the 7
th
 day recall root canal 
treatment is continued in Group IV. Data were analyzed statistically. 
RESULT 
Out of eighty adult volunteers who participated in the study, forty four 
(55%) were males and thirty six (45%) were females. No statistical difference was 
there between the 4 groups selected for the study regarding the preoperative 
parameters. Evaluation of 4 study groups showed a significant reduction in acute 
irreversible pulpitis pain, with intraosseous injection of methyl prednisolone 
acetate (Depo Medrol) when compared to control group saline and antibiotic 
groups which required analgesics till day 7 to control pain. In   Group I methyl 
prednisolone acetate group (Depo Medrol) pulpectomy and Post endodontic 
restoration was performed with more ease and comfort compared to other study 
groups. 
CONCLUSION 
Adequate anesthesia, pain reduction and ability to perform pulpectomy with 
comfort was achieved in   patients after they were administered methyl 
prednisolone acetate (Depo-medrol) compared to control group (saline), 
prophylactic antibiotic group and patients where emergency pulpectomy performed 
with 2% lignocaine containing 1:100000 adrenaline. 
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